Literature DB >> 7531795

Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells.

N Jørgensen1, E Rajpert-De Meyts, N Graem, J Müller, A Giwercman, N E Skakkebaek.   

Abstract

BACKGROUND: It has been hypothesized that carcinoma in situ of the testis (CIS), which is the precursor of invasive testicular germ cell tumours, may arise from fetal germ cells during fetal development rather than later in life. In order to corroborate this hypothesis, we undertook the present study. EXPERIMENTAL
DESIGN: Normal human germ cells from 10 first-trimester fetuses and 76 second- and third-trimester testes were investigated for the immunohistochemical expression of the markers of testicular carcinoma in situ. The panel of markers included in the study consisted of placental-like alkaline phosphatase, the protooncogene c-kit protein product, and the antigens for the monoclonal antibodies TRA-1-60 and M2A. The relative numbers of fetal germ cells that demonstrated positive reaction with the markers were calculated.
RESULTS: The vast majority of the germ cells (75-100%) in the first-trimester gonads were positive for placental-like alkaline phosphatase, TRA-1-60, and M2A. The c-kit protein was detected in three out of the ten first-trimester gonads. The relative number of germ cells positive for all the markers studied declined rapidly during the first part of the second trimester, and the decrease continued with the fetal age.
CONCLUSIONS: The expression of adult carcinoma in situ markers in normal fetal germ cells is consistent with the hypothesis that CIS cells may arise from fetal germ cells, although re-expression of the antigens in postnatally arising CIS cells could provide an alternative explanation. However, we speculate that a transformation of normal fetal germ cells into CIS cells may take place before the end of the 9th week of fetal development. Furthermore, the expression of c-kit in early human fetal germ cells indicates that the c-kit and its ligand play a role in the early human testicular development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531795

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  30 in total

1.  Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.

Authors:  H Roelofs; M C Mostert; K Pompe; G Zafarana; M van Oorschot; R J van Gurp; A J Gillis; H Stoop; B Beverloo; J W Oosterhuis; C Bokemeyer; L H Looijenga
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.

Authors:  L H Looijenga; A J Gillis; R J van Gurp; A J Verkerk; J W Oosterhuis
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 3.  [Testicular intraepithelial neoplasms (TIN). An indication for radiotherapy?].

Authors:  J Classen; K P Dieckmann; V Loy; M Bamberg
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

4.  Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cell tumors of adolescents and adults: clinical and biological implications.

Authors:  H Roelofs; R J van Gurp; J W Oosterhuis; L H Looijenga
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

5.  Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours.

Authors:  Si Brask Sonne; Amy S Herlihy; Christina E Hoei-Hansen; John E Nielsen; Kristian Almstrup; Niels E Skakkebaek; Alexander Marks; Henrik Leffers; Ewa Rajpert-De Meyts
Journal:  Virchows Arch       Date:  2006-05-31       Impact factor: 4.064

6.  Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells.

Authors:  Ralph Brehm; Christina Rüttinger; Petra Fischer; Isabella Gashaw; Elke Winterhager; Sabine Kliesch; Rainer M Bohle; Klaus Steger; Martin Bergmann
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

Review 7.  Testis-preserving strategies in testicular germ cell tumors and germ cell neoplasia in situ.

Authors:  Pia Paffenholz; David Pfister; Axel Heidenreich
Journal:  Transl Androl Urol       Date:  2020-01

8.  Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.

Authors:  Michael C Risk; Timothy A Masterson
Journal:  Indian J Urol       Date:  2010 Jan-Mar

9.  Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte.

Authors:  Si Brask Sonne; Kristian Almstrup; Marlene Dalgaard; Agnieszka Sierakowska Juncker; Daniel Edsgard; Ludmila Ruban; Neil J Harrison; Christian Schwager; Amir Abdollahi; Peter E Huber; Søren Brunak; Lise Mette Gjerdrum; Harry D Moore; Peter W Andrews; Niels E Skakkebaek; Ewa Rajpert-De Meyts; Henrik Leffers
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

10.  TRA-1-60+, SSEA-4+, POU5F1+, SOX2+, NANOG+ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes.

Authors:  Marek Malecki; Xenia Tombokan; Mark Anderson; Raf Malecki; Michael Beauchaine
Journal:  J Stem Cell Res Ther       Date:  2013-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.